ArticleHealth services research2020
Relationship between initiation of 340B participation and hospital safety-net engagement.
Article in Health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Ten-Year Cost Projections for Medicare Beneficiaries 65 Years or Older With HIV.JAMA network open · 2026Article
- Variation, Overlap, and Stability in Defining Safety Net Hospitals.JAMA network open · 2025Article
- Local population characteristics and access equity of 340B contract pharmacies.Health affairs scholar · 2025Article
- What is driving 340B growth: utilization or price?Health affairs scholar · 2025Article
- Expansion of 340B Disproportionate Share Hospitals in the United States From 2010 to 2022.Health services research · 2025Article
- The 340B Drug Pricing Program and Management of Advanced Prostate Cancer.Cancer medicine · 2025Article
- 340B Participation and Safety Net Engagement Among Federally Qualified Health Centers.JAMA health forum · 2024Article
- Addressing financial toxicity in cancer treatment-An opportunity for the 340B drug pricing program.Cancer · 2024Article
- Article
- Assessing the Impact of the 340B Drug Pricing Program: A Scoping Review of the Empirical, Peer-Reviewed Literature.The Milbank quarterly · 2024Article
- US Hospital Service Availability and New 340B Program Participation.JAMA health forum · 2024Article
- Characteristics of 340B Hospitals Receiving Medicare Part B Repayments.JAMA health forum · 2024Article
- 340B Contract pharmacy growth by pharmacy ownership: 2009-2022.Health affairs scholar · 2024Article
- Outcomes of the 340B Drug Pricing Program: A Scoping Review.JAMA health forum · 2023Article
- Trends in Proportion of Medicare Part D Claims Subject to 340B Discounts, 2013-2020.JAMA health forum · 2023Article
- The impacts of the 340B Program on health care quality for low-income patients.Health services research · 2023Article
- Association Between New 340B Program Participation and Commercial Insurance Spending on Outpatient Biologic Oncology Drugs.JAMA health forum · 2023Article
- Access To Oncology Services In Rural Areas: Influence Of The 340B Drug Pricing Program.Health affairs (Project Hope) · 2023Article
- 340B Drug Pricing Program and hospital provision of uncompensated care.The American journal of managed care · 2021Article
- Relationship between initiation of 340B participation and hospital safety-net engagement.Health services research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe 340B program allows safety-net hospitals to acquire discounted outpatient drugs and charge payers full price. We examined whether 340B participation increases safety-net engagement. DATA SOURCES: 340B participation data, Medicare hospital cost reports, American Hospital Association Survey, and Schedule 990 nonprofit hospital tax returns. STUDY
designQuasi-experimental difference-in-differences design comparing 340B hospitals (the "treatment" group) before and after participating to changes over time to three alternative "control" groups: all other nonprofit and public hospitals, hospitals that are not participating during our study, and hospitals that were not-yet-participating but started after 2015. Outcome measures include a range of safety-net care measures that are alternatives to the standard uncompensated care: charity care, community benefit spending, charity care policies, and low-profit service-line provision. DATA EXTRACTION: We extracted data on all nonprofit and public hospitals from 2011 to 2015. We linked 340B participation data to Medicare hospital cost reports and American Hospital Association data using Medicare hospital identifiers. 990 Data was linked on name and address. PRINCIPAL
findingsNew 340B participation was not associated with a change in uncompensated care, but was associated with a 28.9 percent increase in charity care spending (SE = 8.8), or about $880,000 per hospital. However, total community benefit spending (including charity care) did not change. 340B was associated with an increase in the probability of offering discounted care (4.3 percentage points, SE = 1.6) from 84 to 88 percent and an increase in the income eligibility limit for discounted care (18.9 percentage points, SE = 5.6) from 294 to 313 percent. Participation was not associated with the probability of offering low-profit medical care services.
conclusionsAlternative measures show that newly participating hospitals may increase charity care, potentially through offering more patients discounted care. However, increases appear to be fully offset by reductions in other community benefit programs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.